Key stats
About CAPITAL INV TRUST CORP NASDAQ BIOTECHNOLOGY ETF TWD
Home page
Inception date
Jan 9, 2017
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Capitalizes
Primary advisor
Qunyi Securities Investment Trust Co. Ltd.
ISIN
TW0000067800
This fund invests in one basket of United States biotechnology stocks, providing investors with direct participation in the US biotechnology market, which can save investors’ cost and time. The ETF tracks “Nasdaq Biotechnology Index” performance as the management target
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks96.67%
Health Technology93.49%
Technology Services1.32%
Commercial Services1.23%
Health Services0.61%
Process Industries0.01%
Bonds, Cash & Other3.33%
Cash1.82%
ETF1.50%
Miscellaneous0.01%
Stock breakdown by region
North America83.14%
Europe16.77%
Asia0.08%
Oceania0.02%
Latin America0.00%
Africa0.00%
Middle East0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
00678 invests in stocks. The fund's major sectors are Health Technology, with 93.49% stocks, and Technology Services, with 1.32% of the basket. The assets are mostly located in the North America region.
00678 top holdings are Gilead Sciences, Inc. and Vertex Pharmaceuticals Incorporated, occupying 8.49% and 8.19% of the portfolio correspondingly.
00678 assets under management is 217.79 M TWD. It's fallen 8.91% over the last month.
00678 fund flows account for 29.28 M TWD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, 00678 doesn't pay dividends to its holders.
00678 shares are issued by Qunyi Securities Investment Trust Co. Ltd. under the brand Capital. The ETF was launched on Jan 9, 2017, and its management style is Passive.
00678 expense ratio is 1.01% meaning you'd have to pay 1.01% of your investment to help manage the fund.
00678 follows the NASDAQ Biotechnology Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
00678 invests in stocks.
00678 price has fallen by −8.86% over the last month, and its yearly performance shows a −12.33% decrease. See more dynamics on 00678 price chart.
NAV returns, another gauge of an ETF dynamics, have fallen by −8.82% over the last month, showed a −16.45% decrease in three-month performance and has decreased by −15.45% in a year.
NAV returns, another gauge of an ETF dynamics, have fallen by −8.82% over the last month, showed a −16.45% decrease in three-month performance and has decreased by −15.45% in a year.
00678 trades at a premium (0.33%) meaning the ETF is trading at a higher price than the calculated NAV.